+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pharmacovigilance and Drug Safety Software Market 2019-2023 - Product Image

Global Pharmacovigilance and Drug Safety Software Market 2019-2023

  • ID: 4792939
  • Report
  • Region: Global
  • 121 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.
  • MORE
Global Pharmacovigilance and Drug Safety Software Market: About this market

Pharmacovigilance and drug safety software are used in the creation, classification, assessment, reviewal, submission, and maintenance of adverse drug events and pharmacovigilance data. This pharmacovigilance and drug safety software market analysis considers sales from end-users pharmaceutical and biotechnology companies, contract research organization, and business process outsourcing. Our analysis also considers the sales of pharmacovigilance and drug safety software in APAC, Europe, North America, and ROW. In 2018, the pharmaceutical and biotechnology companies segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the release of new drugs in countries such as the US, Japan, and Canada will play a significant role in the pharmaceutical and biotechnology companies segment to maintain its market position. Also, our global pharmacovigilance and drug safety software market report looks at factors such as rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals for new molecules and biosimilars. However, high cost of ownership, installation, and maintenance, concerns related to data safety and security, and issues related to system integration may hamper the growth of the pharmacovigilance and drug safety software industry over the forecast period.

Global Pharmacovigilance and Drug Safety Software market: Overview

Increasing approvals for new molecules and biosimilars

New molecules and biosimilars undergo drug safety assessments before their launch in the market. This is to ensure that the drugs comply with safety standards as per regulations. This rise in approval of new molecular entities and biosimilars as well as registered activities of clinical trials globally has resulted in a surge in the adoption of pharmacovigilance and drug safety software which will subsequently lead to the expansion of the global pharmacovigilance and drug safety software market at a CAGR of close to 7% during the forecast period.

Outsourcing pharmacovigilance and drug safety research to CROs

To reduce the operational costs and provide revenue-generating opportunities to the vendors, pharmacovigilance, and drug safety operations are being outsourced to developing economies such as India, China, and the Philippines. This trend is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global pharmacovigilance and drug safety software market is moderately concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software manufacturers, that includes AB Cube, ArisGlobal LLC, Ennov, EXTEDO GmbH, and Oracle Corp.

Also, the pharmacovigilance and drug safety software market analysis report include information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies
  • Market size and forecast 2018-2023
  • Contract research organization - Market size and forecast 2018-2023
  • Business process outsourcing - Market size and forecast 2018-2023
  • Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Integration of AI in pharmacovigilance
  • Outsourcing pharmacovigilance and drug safety research to CROs
  • Extensive adoption of cloud technologies in pharmaceutical manufacturing and testing
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: End-user - Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
Exhibit 21: Contract research organization - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Contract research organization - Year-over-year growth 2019-2023 (%)
Exhibit 23: Business process outsourcing - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Business process outsourcing - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: AB Cube - Vendor overview
Exhibit 46: AB Cube - Business segments
Exhibit 47: AB Cube - Organizational developments
Exhibit 48: AB Cube - Key offerings
Exhibit 49: ArisGlobal LLC - Vendor overview
Exhibit 50: ArisGlobal LLC - Product segments
Exhibit 51: ArisGlobal LLC - Organizational developments
Exhibit 52: ArisGlobal LLC - Key offerings
Exhibit 53: Ennov - Vendor overview
Exhibit 54: Ennov - Business segments
Exhibit 55: Ennov - Organizational developments
Exhibit 56: Ennov - Key offerings
Exhibit 57: EXTEDO GmbH - Vendor overview
Exhibit 58: EXTEDO GmbH - Business segments
Exhibit 59: EXTEDO GmbH - Organizational developments
Exhibit 60: EXTEDO GmbH - Key offerings
Exhibit 61: Oracle Corp. - Vendor overview
Exhibit 62: Oracle Corp. - Business segments
Exhibit 63: Oracle Corp. - Organizational developments
Exhibit 64: Oracle Corp. - Geographic focus
Exhibit 65: Oracle Corp. - Segment focus
Exhibit 66: Oracle Corp. - Key offerings
Exhibit 67: Validation techniques employed for market sizing
Exhibit 68: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.
  • MORE
The following companies are recognised as the key players in the global pharmacovigilance and drug safety software market: AB Cube, ArisGlobal LLC, Ennov, EXTEDO GmbH, and Oracle Corp.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the outsourcing pharmacovigilance and drug safety research to CROs”.

According to the report, one of the major drivers for this market is the increasing approvals for new molecules and biosimilars.

Further, the report states that one of the major factors hindering the growth of this market is the issues related to system integration.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.
Note: Product cover images may vary from those shown
Adroll
adroll